PRESS RELEASE August 5 , 202 2 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that 6,45 0, 734 options have forfeited in 20 22, leading to a reduction in potential dilution from 11.89% to 3.0 6 %. As of December 31, 2021, the company had 8,402,181 options

PRESS RELEASE 15 July 202 2 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders in Saniona AB, Reg. No. 556962-5345, are hereby invited to attend the extraordinary general

PRESS RELEASE Ju ly 6 , 202 2 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that the CEO and a member of the B oard of Directors have purchased 2 4 0 ,221 shares of the company in the open market for a total value of approximately SEK 0 . 9 million .